Showing results (1961-1970 of 2,148) with videos related to

Sort By:
Pageof 215
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2014
The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?Flora H Duits, Charlotte E Teunissen, Femke H Bouwman, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Biological Psychiatry|April 1, 2020
The β-Secretase BACE1 in Alzheimer's DiseaseHarald Hampel, Robert Vassar, Bart De Strooper, et al.
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Neurobiology of Aging|March 1, 2020
Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer's neuropathology and high education level: the INSIGHT-preAD studyClaudio Babiloni, Susanna Lopez, Claudio Del Percio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer riskT S Frank, S A Manley, O I Olopade, et al.
Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2026
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractionsJessica F Burlile, William S Harmsen, Sydney D Suddendorf, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Pageof 215